Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the β2‐adrenergic receptor
Open Access
- 1 April 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (7) , 1715-1722
- https://doi.org/10.1038/sj.bjp.0704622
Abstract
We compared the changes in binding energy generated by two mutations that shift in divergent directions the constitutive activity of the human β2 adrenergic receptor (β2AR). A constitutively activating mutant (CAM) and the double alanine replacement (AA mutant) of catechol‐binding serines (S204A, S207A) in helix 5 were stably expressed in CHO cell lines, and used to measure the binding affinities of more than 40 adrenergic ligands. Moreover, the efficacy of the same group of compounds was determined as intrinsic activity for maximal adenylyl cyclase stimulation in wild‐type β2AR. Although the two mutations had opposite effects on ligand affinity, the extents of change were in both cases largely correlated with the degree of ligand efficacy. This was particularly evident if the extra loss of binding energy due to hydrogen bond deletion in the AA mutant was taken into account. Thus the data demonstrate that there is an overall linkage between the configuration of the binding pocket and the intrinsic equilibrium between active and inactive receptor forms. We also found that AA mutation‐induced affinity changes for catecholamine congeners gradually lacking ethanolamine substituents were linearly correlated to the loss of affinity that such modifications of the ligand cause for wild‐type receptor. This indicates that the strength of bonds between catechol ring and helix 5 is critically dependent on the rest of interactions of the β‐ethanolamine tail with other residues of the β2‐AR binding pocket. British Journal of Pharmacology (2002) 135, 1715–1722; doi:10.1038/sj.bjp.0704622Keywords
This publication has 19 references indexed in Scilit:
- The Forgotten SerineJournal of Biological Chemistry, 2000
- Differential Modes of Agonist Binding to 5-Hydroxytryptamine2A Serotonin Receptors Revealed by Mutation and Molecular Modeling of Conserved Residues in Transmembrane Region 5Molecular Pharmacology, 2000
- Catechol-binding serines of beta(2)-adrenergic receptors control the equilibrium between active and inactive receptor states.2000
- Study of Interaction between Agonists and Asn293 in Helix VI of Human β2-Adrenergic ReceptorMolecular Pharmacology, 1999
- Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.Proceedings of the National Academy of Sciences, 1996
- Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.1996
- A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious pubertyNature, 1993
- Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomasNature, 1993
- IDENTIFICATION OF 2 SERINE RESIDUES INVOLVED IN AGONIST ACTIVATION OF THE BETA-ADRENERGIC-RECEPTOR1989
- Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.Journal of Biological Chemistry, 1988